Blau Farmacêutica S.A. (BVMF: BLAU3)

Market Cap	2.48B
Revenue (ttm)	1.57B
Net Income (ttm)	217.68M
Shares Out	177.68M
EPS (ttm)	1.23
PE Ratio	11.36
Forward PE	10.08
Dividend	0.75 (5.52%)
Ex-Dividend Date	Jun 27, 2024

Volume	145,900
Open	13.68
Previous Close	13.55
Day's Range	13.48 - 13.91
52-Week Range	9.20 - 17.73
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital produc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2023, Blau Farmacêutica's revenue was 1.37 billion, a decrease of -2.44% compared to the previous year's 1.41 billion. Earnings were 249.81 million, a decrease of -31.25%.